Deletion of ADORA2B from myeloid cells dampens lung fibrosis and pulmonary hypertension

FASEB Journal

Volumn 29, Issue 1, 2015, Pages 50-60

  Karmouty Quintana, Harry ^a   Philip, Kemly ^a   Acero, Luis F ^a   Chen, Ning Yuan ^a   Weng, Tingting ^a   Molina, Jose G ^a   Luo, Fayong ^a   Davies, Jonathan ^b   Le, Ngoc Bao ^a   Bunge, Isabelle ^a   Volcik, Kelly A ^a   Le, Thanh Thuy T ^a   Johnston, Richard A ^a   Xia, Yang ^a   Eltzschig, Holger K ^c   Blackburn, Michael R ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine receptors; Alternatively activated macrophages; Hyaluronan; Vascular remodeling

Indexed keywords

ADENOSINE RECEPTOR; ADENOSINE RECEPTOR A2B; ARGINASE 1; BIOLOGICAL MARKER; BLEOMYCIN; CD206; HYALURONIC ACID; INTERLEUKIN 6; UNCLASSIFIED DRUG; ADENOSINE A2B RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BONE MARROW CELL; CONTROLLED STUDY; DISEASE COURSE; EXPERIMENTAL MODEL; HISTOLOGY; INFLAMMATION; KNOCKOUT MOUSE; LUNG COMPLIANCE; LUNG FIBROSIS; LUNG FUNCTION; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; DEFICIENCY; DISEASE MODEL; GENETICS; HUMAN; HYPERTENSION, PULMONARY; IDIOPATHIC PULMONARY FIBROSIS; MACROPHAGE ACTIVATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

MUS;

ANIMALS; BLEOMYCIN; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION, PULMONARY; IDIOPATHIC PULMONARY FIBROSIS; MACROPHAGE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID CELLS; RECEPTOR, ADENOSINE A2B;

EID: 84937391124     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-260182     Document Type: Article

References (43)

1. Blackwell, T. S., Tager, A. M., Borok, Z., Moore, B. B., Schwartz, D. A., Anstrom, K. J., Bar-Joseph, Z., Bitterman, P., Blackburn, M. R., Bradford, W., Brown, K. K., Chapman, H. A., Collard, H. R., Cosgrove, G. P., Deterding, R., Doyle, R., Flaherty, K. R., Garcia, C. K., Hagood, J. S., Henke, C. A., Herzog, E., Hogaboam, C. M., Horowitz, J. C., King, Jr., T. E., Loyd, J. E., Lawson, W. E., Marsh, C. B., Noble, P. W., Noth, I., Sheppard, D., Olsson, J., Ortiz, L. A., O'Riordan, T. G., Oury, T. D., Raghu, G., Roman, J., Sime, P. J., Sisson, T. H., Tschumperlin, D., Violette, S. M., Weaver, T. E., Wells, R. G., White, E. S., Kaminski, N., Martinez, F. J., Wynn, T. A., Thannickal, V. J., and Eu, J. P. (2014) Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report. Am. J. Respir. Crit. Care Med. 189, 214-222
2. Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J. F., Flaherty, K. R., Lasky, J. A., Lynch, D. A., Ryu, J. H., Swigris, J. J., Wells, A. U., Ancochea, J., Bouros, D., Carvalho, C., Costabel, U., Ebina, M., Hansell, D. M., Johkoh, T., Kim, D. S., King, Jr., T. E., Kondoh, Y., Myers, J., Muller, N. L., Nicholson, A. G., Richeldi, L., Selman, M., Dudden, R. F., Griss, B. S., Protzko, S. L., and Schunemann, H. J.; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 183, 788-824
3. Behr, J., and Ryu, J. H. (2008) Pulmonary hypertension in interstitial lung disease. Eur. Respir. J. 31, 1357-1367
4. El Chami, H., and Hassoun, P. M. (2012) Immune and inflammatory mechanisms in pulmonary arterial hypertension. Prog. Cardiovasc. Dis. 55, 218-228
5. Baran, C. P., Opalek, J. M., McMaken, S., Newland, C. A., O'Brien, Jr., J. M., Hunter, M. G., Bringardner, B. D., Monick, M. M., Brigstock, D. R., Stromberg, P. C., Hunninghake, G. W., and Marsh, C. B. (2007) Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 176, 78-89
6. Lacronique, J. G., Rennard, S. I., Bitterman, P. B., Ozaki, T., and Crystal, R. G. (1984) Alveolar macrophages in idiopathic pulmonary fibrosis have glucocorticoid receptors, but glucocorticoid therapy does not suppress alveolar macrophage release of fibronectin and alveolar macrophage derived growth factor. Am. Rev. Respir. Dis. 130, 450-456
7. Mora, A. L., Torres-González, E., Rojas, M., Corredor, C., Ritzenthaler, J., Xu, J., Roman, J., Brigham, K., and Stecenko, A. (2006) Activation of alveolar macrophages via the alternative pathway in herpesvirus-induced lung fibrosis. Am. J. Respir. Cell Mol. Biol. 35, 466-473
8. Tuder, R. M., Groves, B., Badesch, D. B., and Voelkel, N. F. (1994) Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am. J. Pathol. 144, 275-285
9. Vergadi, E., Chang, M. S., Lee, C., Liang, O. D., Liu, X., Fernandez-Gonzalez, A., Mitsialis, S. A., and Kourembanas, S. (2011) Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension. Circulation 123, 1986-1995
10. Zhou, Y., Murthy, J. N., Zeng, D., Belardinelli, L., and Blackburn, M. R. (2010) Alterations in adenosine metabolism and signaling in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. PLoS ONE 5, e9224
11. Karmouty-Quintana, H., Xia, Y., and Blackburn, M. R. (2013) Adenosine signaling during acute and chronic disease states. J. Mol. Med. 91, 173-181
12. Karmouty-Quintana, H., Weng, T., Garcia-Morales, L. J., Chen, N. Y., Pedroza, M., Zhong, H., Molina, J. G., Bunge, R., Bruckner, B. A., Xia, Y., Johnston, R. A., Loebe, M., Zeng, D., Seethamraju, H., Belardinelli, L., and Blackburn, M. R. (2013) Adenosine A2B receptor and hyaluronan modulate pulmonary hypertension associated with chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 49, 1038-1047
13. Sun, C. X., Zhong, H., Mohsenin, A., Morschl, E., Chunn, J. L., Molina, J. G., Belardinelli, L., Zeng, D., and Blackburn, M. R. (2006) Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. J. Clin. Invest. 116, 2173-2182
14. Zimmerman, M. A., Grenz, A., Tak, E., Kaplan, M., Ridyard, D., Brodsky, K. S., Mandell, M. S., Kam, I., and Eltzschig, H. K. (2013) Signaling through hepatocellular A2B adenosine receptors dampens ischemia and reperfusion injury of the liver. Proc. Natl. Acad. Sci. USA 110, 12012-12017
15. Karmouty-Quintana, H., Zhong, H., Acero, L., Weng, T., Melicoff, E., West, J. D., Hemnes, A., Grenz, A., Eltzschig, H. K., Blackwell, T. S., Xia, Y., Johnston, R. A., Zeng, D., Belardinelli, L., and Blackburn, M. R. (2012) The A2B adenosine receptor modulates pulmonary hypertension associated with interstitial lung disease. FASEB J. 26, 2546-2557
16. Johnston, R. A., Theman, T. A., Lu, F. L., Terry, R. D., Williams, E. S., and Shore, S. A. (2008) Diet-induced obesity causes innate airway hyperresponsiveness to methacholine and enhances ozone-induced pulmonary inflammation. J. Appl. Physiol. 104, 1727-1735
17. Shalaby, K. H., Gold, L. G., Schuessler, T. F., Martin, J. G., and Robichaud, A. (2010) Combined forced oscillation and forced expiration measurements in mice for the assessment of airway hyperresponsiveness. Respir. Res. 11, 82
18. Hubner, R. H., Gitter, W., El Mokhtari, N. E., Mathiak, M., Both, M., Bolte, H., Freitag-Wolf, S., and Bewig, B. (2008) Standardized quantification of pulmonary fibrosis in histological samples. Biotechniques 44, 507-511, 514-517
19. Wakamiya, M., Blackburn, M. R., Jurecic, R., McArthur, M. J., Geske, R. S., Cartwright, Jr., J., Mitani, K., Vaishnav, S., Belmont, J. W., Kellems, R. E., Finegold, M. J., Montgomery, C. A., Bradley, A., and Caskey, C. T. (1995) Disruption of the adenosine deaminase gene causes hepatocellular impairment and perinatal lethality in mice. Proc. Natl. Acad. Sci. USA 92, 3673-3677
20. Zhou, Y., Schneider, D. J., and Blackburn, M. R. (2009) Adenosine signaling and the regulation of chronic lung disease. Pharmacol. Ther. 123, 105-116
21. Ask, K., Labiris, R., Farkas, L., Moeller, A., Froese, A., Farncombe, T., McClelland, G. B., Inman, M., Gauldie, J., and Kolb, M. R. (2008) Comparison between conventional and "clinical" assessment of experimental lung fibrosis. J. Transl. Med. 6, 16
22. Pitsiou, G., Papakosta, D., and Bouros, D. (2011) Pulmonary hypertension in idiopathic pulmonary fibrosis: a review. Respiration 82, 294-304
23. Shorr, A. F., Wainright, J. L., Cors, C. S., Lettieri, C. J., and Nathan, S. D. (2007) Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur. Respir. J. 30, 715-721
24. Murray, P. J., and Wynn, T. A. (2011) Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11, 723-737
25. Shaykhiev, R., Krause, A., Salit, J., Strulovici-Barel, Y., Harvey, B. G., O'Connor, T. P., and Crystal, R. G. (2009) Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease. J. Immunol. 183, 2867-2883
26. Chaouat, A., Savale, L., Chouaid, C., Tu, L., Sztrymf, B., Canuet, M., Maitre, B., Housset, B., Brandt, C., Le Corvoisier, P., Weitzenblum, E., Eddahibi, S., and Adnot, S. (2009) Role for interleukin-6 in COPD-related pulmonary hypertension. Chest 136, 678-687
27. Knight, D. A., Ernst, M., Anderson, G. P., Moodley, Y. P., and Mutsaers, S. E. (2003) The role of gp130/IL-6 cytokines in the development of pulmonary fibrosis: critical determinants of disease susceptibility and progression? Pharmacol. Ther. 99, 327-338
28. Pedroza, M., Schneider, D. J., Karmouty-Quintana, H., Coote, J., Shaw, S., Corrigan, R., Molina, J. G., Alcorn, J. L., Galas, D., Gelinas, R., and Blackburn, M. R. (2011) Interleukin-6 contributes to inflammation and remodeling in a model of adenosine mediated lung injury. PLoS ONE 6, e22667
29. Steiner, M. K., Syrkina, O. L., Kolliputi, N., Mark, E. J., Hales, C. A., and Waxman, A. B. (2009) Interleukin-6 overexpression induces pulmonary hypertension. Circ. Res. 104, 236-244, 28p following 244
30. Aytekin, M., Comhair, S. A., de la Motte, C., Bandyopadhyay, S. K., Farver, C. F., Hascall, V. C., Erzurum, S. C., and Dweik, R. A. (2008) High levels of hyaluronan in idiopathic pulmonary arterial hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol. 295, L789-L799
31. Li, Y., Jiang, D., Liang, J., Meltzer, E. B., Gray, A., Miura, R., Wogensen, L., Yamaguchi, Y., and Noble, P. W. (2011) Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44. J. Exp. Med. 208, 1459-1471
32. Zhou, Y., Schneider, D. J., Morschl, E., Song, L., Pedroza, M., Karmouty-Quintana, H., Le, T., Sun, C. X., and Blackburn, M. R. (2011) Distinct roles for the A2B adenosine receptor in acute and chronic stages of bleomycin-induced lung injury. J. Immunol. 186, 1097-1106
33. Colgan, S. P., Eltzschig, H. K., Eckle, T., and Thompson, L. F. (2006) Physiological roles for ecto-59-nucleotidase (CD73). Purinergic Signal. 2, 351-360
34. Toldo, S., Zhong, H., Mezzaroma, E., Van Tassell, B. W., Kannan, H., Zeng, D., Belardinelli, L., Voelkel, N. F., and Abbate, A. (2012) GS-6201, a selective blocker of the A2B adenosine receptor, attenuates cardiac remodeling after acute myocardial infarction in the mouse. J. Pharmacol. Exp. Ther. 343, 587-595
35. Nagaoka, I., Trapnell, B. C., and Crystal, R. G. (1990) Upregulation of platelet-derived growth factor-A and -B gene expression in alveolar macrophages of individuals with idiopathic pulmonary fibrosis. J. Clin. Invest. 85, 2023-2027
36. Prasse, A., Pechkovsky, D. V., Toews, G. B., Jungraithmayr, W., Kollert, F., Goldmann, T., Vollmer, E., Müller-Quernheim, J., and Zissel, G. (2006) A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am. J. Respir. Crit. Care Med. 173, 781-792
37. Gibbons, M. A., MacKinnon, A. C., Ramachandran, P., Dhaliwal, K., Duffin, R., Phythian-Adams, A. T., van Rooijen, N., Haslett, C., Howie, S. E., Simpson, A. J., Hirani, N., Gauldie, J., Iredale, J. P., Sethi, T., and Forbes, S. J. (2011) Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. Am. J. Respir. Crit. Care Med. 184, 569-581
38. Frid, M. G., Brunetti, J. A., Burke, D. L., Carpenter, T. C., Davie, N. J., Reeves, J. T., Roedersheimer, M. T., van Rooijen, N., and Stenmark, K. R. (2006) Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am. J. Pathol. 168, 659-669
39. Sahara, M., Sata, M., Morita, T., Nakamura, K., Hirata, Y., and Nagai, R. (2007) Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation. Circulation 115, 509-517
40. Tian, W., Jiang, X., Tamosiuniene, R., Sung, Y. K., Qian, J., Dhillon, G., Gera, L., Farkas, L., Rabinovitch, M., Zamanian, R. T., Inayathullah, M., Fridlib, M., Rajadas, J., Peters-Golden, M., Voelkel, N. F., and Nicolls, M. R. (2013) Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension. Sci. Transl. Med. 5, 200ra117
41. Belikoff, B. G., Vaickus, L. J., Sitkovsky, M., and Remick, D. G. (2012) A2B adenosine receptor expression by myeloid cells is proinflammatory in murine allergic-airway inflammation. J. Immunol. 189, 3707-3713
42. Cloots, R. H., Sankaranarayanan, S., de Theije, C. C., Poynter, M. E., Terwindt, E., van Dijk, P., Hakvoort, T. B., Lamers, W. H., and Köhler, S. E. (2013) Ablation of Arg1 in hematopoietic cells improves respiratory function of lung parenchyma, but not that of larger airways or inflammation in asthmatic mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 305, L364-L376
43. Chang, M. Y., Tanino, Y., Vidova, V., Kinsella, M. G., Chan, C. K., Johnson, P. Y., Wight, T. N., and Frevert, C. W. (2014) Reprint of: A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease. Matrix Biol. 35, 162-173